Immune profiling enables stratification of patients with active tuberculosis disease or mycobacterium tuberculosis infection
dc.contributor.author | Duffy, Darragh | en_ZA |
dc.contributor.author | Nemes, Elisa | en_ZA |
dc.contributor.author | Llibre, Alba | en_ZA |
dc.contributor.author | Rouilly, Vincent | en_ZA |
dc.contributor.author | Musvosvi, Munyaradzi | en_ZA |
dc.contributor.author | Smith, Nikaïa | en_ZA |
dc.contributor.author | Filander, Elizabeth | en_ZA |
dc.contributor.author | Africa, Hadn | en_ZA |
dc.contributor.author | Mabwe, Simbarashe | en_ZA |
dc.contributor.author | Jaxa, Lungisa | en_ZA |
dc.contributor.author | Charbit, Bruno | en_ZA |
dc.contributor.author | Mulenga, Humphrey | en_ZA |
dc.contributor.author | Tameris, Michele | en_ZA |
dc.contributor.author | Walzl, Gerhard | en_ZA |
dc.contributor.author | Malherbe, Stephanus | en_ZA |
dc.contributor.author | Thomas, Stephanie | en_ZA |
dc.contributor.author | Hatherill, Mark | en_ZA |
dc.contributor.author | Bilek, Nicole | en_ZA |
dc.contributor.author | Scriba, Thomas J. | en_ZA |
dc.contributor.author | Albert, Matthew L. | en_ZA |
dc.date.accessioned | 2022-06-03T08:42:39Z | en_ZA |
dc.date.available | 2022-06-03T08:42:39Z | en_ZA |
dc.date.issued | 2020-10 | en_ZA |
dc.description | CITATION: Duffy, D. et al. Immune profiling enables stratification of patients with active tuberculosis disease or mycobacterium tuberculosis infection. Clinical Infectious Diseases, 73(9):e3398–e3408, doi:10.1093/cid/ciaa1562 | en_ZA |
dc.description | The original publication is available at https://academic.oup.com/cid/ | en_ZA |
dc.description.abstract | Background Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) infection and is a major public health problem. Clinical challenges include the lack of a blood-based test for active disease. Current blood-based tests, such as QuantiFERON (QFT) do not distinguish active TB disease from asymptomatic Mtb infection. Methods We hypothesized that TruCulture, an immunomonitoring method for whole-blood stimulation, could discriminate active disease from latent Mtb infection (LTBI). We stimulated whole blood from patients with active TB and compared with LTBI donors. Mtb-specific antigens and live bacillus Calmette-Guérin (BCG) were used as stimuli, with direct comparison to QFT. Protein analyses were performed using conventional and digital enzyme-linked immunosorbent assay (ELISA), as well as Luminex. Results TruCulture showed discrimination of active TB cases from LTBI (P < .0001, AUC = .81) compared with QFT (P = .45, AUC = .56), based on an interferon γ (IFNγ) readout after Mtb antigen (Ag) stimulation. This result was replicated in an independent cohort (AUC = .89). In exploratory analyses, TB stratification could be further improved by the Mtb antigen to BCG IFNγ ratio (P < .0001, AUC = .91). Finally, the combination of digital ELISA and transcriptional analysis showed that LTBI donors with high IFNγ clustered with patients with TB, suggesting the possibility to identify subclinical disease. Conclusions TruCulture offers a next-generation solution for whole-blood stimulation and immunomonitoring with the possibility to discriminate active and latent infection. | en_ZA |
dc.description.uri | https://academic.oup.com/cid/article/73/9/e3398/5924452 | en_ZA |
dc.description.version | Publishers version | en_ZA |
dc.format.extent | 11 pages | en_ZA |
dc.identifier.citation | Duffy, D. et al. Immune profiling enables stratification of patients with active tuberculosis disease or mycobacterium tuberculosis infection. Clinical Infectious Diseases, 73(9):e3398–e3408, doi:10.1093/cid/ciaa1562 | en_ZA |
dc.identifier.issn | 1537-6591 (online) | en_ZA |
dc.identifier.issn | 1058-4838 (print) | en_ZA |
dc.identifier.other | doi:10.1093/cid/ciaa1562 | en_ZA |
dc.identifier.uri | http://hdl.handle.net/10019.1/125309 | en_ZA |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Oxford University Press | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Tuberculosis -- Treatment | en_ZA |
dc.subject | Immune profiling | en_ZA |
dc.subject | Patient stratification | en_ZA |
dc.subject | Cytokines | en_ZA |
dc.subject | Biochemical markers | en_ZA |
dc.subject | Mycobacterium tuberculosis | en_ZA |
dc.subject | Public health administration | en_ZA |
dc.title | Immune profiling enables stratification of patients with active tuberculosis disease or mycobacterium tuberculosis infection | en_ZA |
dc.type | Article | en_ZA |